Basis: Trailing twelve months (TTM), to the latest fiscal quarter end. Source: stored company filings and market data; unavailable inputs remain N/A.
Is the return on invested capital (ROIC) high or low?
The return on invested capital (ROIC) of -28.14% is 53% above its 2-year average of -60.37%, near the high end of its 2-year range (-383.73%–-20.48%).
As of the fiscal period ended Tuesday, June 30, 2026. 5.97% above its 12-month average of -29.92%.
Trailing-twelve-month return on invested capital at each fiscal quarter end; no daily interpolation. Q2 FY2026 (2026-06-30): -28.14%.
RETURN ON INVESTED CAPITAL (ROIC)
-28.14%
RETURN ON INVESTED CAPITAL (ROIC) AVG TTM
-29.92%
RETURN ON INVESTED CAPITAL (ROIC) AVG 3Y
N/A
RETURN ON INVESTED CAPITAL (ROIC) AVG 5Y
N/A
RETURN ON INVESTED CAPITAL (ROIC) AVG 10Y
N/A
RETURN ON INVESTED CAPITAL (ROIC) AVG 15Y
N/A
RETURN ON INVESTED CAPITAL (ROIC) AVG 20Y
N/A
CURRENT VS TTM AVG
+5.97%
CURRENT VS 3Y AVG
N/A
CURRENT VS 5Y AVG
N/A
CURRENT VS 10Y AVG
N/A
CURRENT VS 15Y AVG
N/A
CURRENT VS 20Y AVG
N/A
SECTOR MEDIAN · HEALTHCARE
-34.10%
median of 605 covered companies
CURRENT VS SECTOR MEDIAN
+17.49%
vs the sector median at left
BioAge Labs Inc.
Market Cap
$233.43M
Return on Invested Capital (ROIC)
-28.14%
TTM Avg
-29.92%
3Y Avg
N/A
5Y Avg
N/A
Market Cap
$231.35M
Return on Invested Capital (ROIC)
-40.52%
TTM Avg
-35.57%
3Y Avg
-28.84%
5Y Avg
-24.57%
Market Cap
$235.77M
Return on Invested Capital (ROIC)
-1718.59%
TTM Avg
-749.70%
3Y Avg
-566.74%
5Y Avg
-409.31%
Market Cap
$236.81M
Return on Invested Capital (ROIC)
1.38%
TTM Avg
-1.85%
3Y Avg
-13.83%
5Y Avg
-10.66%
Market Cap
$230.02M
Return on Invested Capital (ROIC)
-16.87%
TTM Avg
-43.46%
3Y Avg
-51.45%
5Y Avg
-53.92%
Market Cap
$236.93M
Return on Invested Capital (ROIC)
-7.08%
TTM Avg
-12.89%
3Y Avg
-21.42%
5Y Avg
-39.95%
Market Cap
$238.61M
Return on Invested Capital (ROIC)
-25.38%
TTM Avg
-99.58%
3Y Avg
-69.59%
5Y Avg
-61.10%
Market Cap
$227.52M
Return on Invested Capital (ROIC)
-25.73%
TTM Avg
-40.62%
3Y Avg
-54.07%
5Y Avg
-54.31%
Market Cap
$240.34M
Return on Invested Capital (ROIC)
-69.76%
TTM Avg
-64.00%
3Y Avg
-45.05%
5Y Avg
-31.07%
| NAME | MARKET CAP | RETURN ON INVESTED CAPITAL (ROIC) | TTM | 3Y | 5Y |
|---|---|---|---|---|---|
| BioAge Labs Inc. (BIOA) | $233.43M | -28.14% | -29.92% | N/A | N/A |
| Nautilus Biotechnolgy, Inc. (NAUT)vs › | $231.35M | -40.52% | -35.57% | -28.84% | -24.57% |
| Galectin Therapeutics Inc. (GALT)vs › | $235.77M | -1718.59% | -749.70% | -566.74% | -409.31% |
| High Tide Inc. (HITI)vs › | $236.81M | 1.38% | -1.85% | -13.83% | -10.66% |
| MacroGenics, Inc. (MGNX)vs › | $230.02M | -16.87% | -43.46% | -51.45% | -53.92% |
| Akebia Therapeutics, Inc. (AKBA)vs › | $236.93M | -7.08% | -12.89% | -21.42% | -39.95% |
| InflaRx N.V. (IFRX)vs › | $238.61M | -25.38% | -99.58% | -69.59% | -61.10% |
| Biodesix, Inc. (BDSX)vs › | $227.52M | -25.73% | -40.62% | -54.07% | -54.31% |
| CAMP4 Therapeutics Corporation (CAMP)vs › | $240.34M | -69.76% | -64.00% | -45.05% | -31.07% |
| Invivyd, Inc. (IVVD)vs › | $243.08M | -59.90% | -142.39% | -118.24% | -103.50% |
ROIC
-28.1%
ROE
-25.2%
ROIC = NOPAT / Invested Capital, where NOPAT = Operating Income × (1 − effective tax rate) and Invested Capital = Total Assets − (Current Liabilities − Short-Term Debt)
Return on invested capital measures the after-tax operating return a company earns on the capital invested in the business. TGMCharts computes it from reported statements: trailing-twelve-month operating income after tax, over invested capital at the latest balance sheet — total assets less the non-interest-bearing current liabilities (payables, accruals, deferred revenue) that fund them; short-term debt stays in the capital base. The tax rate is the period's own effective rate (income tax ÷ pretax income), capped at 45%; when pretax income is zero or negative, or the tax line is a net benefit, no tax is deducted — the operating figure is shown untaxed rather than adjusted by an assumed rate. Not shown for banks, insurers or funds.
Expanded definitions: Investopedia, Wikipedia, Corporate Finance Institute
| DATE | RETURN ON INVESTED CAPITAL (ROIC) |
|---|---|
| 2026-06-30 | -28.14% |
| 2026-03-31 | -26.56% |
| 2025-12-31 | -33.45% |
| 2025-09-30 | -31.51% |
| 2025-06-30 | -29.95% |
| 2025-03-31 | -25.09% |
| 2024-12-31 | -23.24% |
| 2024-09-30 | -20.48% |
| 2024-06-30 | -32.76% |
| 2024-03-31 | -29.16% |
| 2023-12-31 | -383.73% |
